ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 17 filers reported holding ARCA BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $662,000 | -55.1% | 232,245 | -55.5% | 0.09% | -38.2% |
Q3 2016 | $1,476,000 | -9.6% | 521,606 | -7.3% | 0.15% | -32.7% |
Q2 2016 | $1,632,000 | -39.6% | 562,693 | -27.7% | 0.23% | -34.5% |
Q1 2016 | $2,700,000 | -25.4% | 778,211 | 0.0% | 0.34% | -3.6% |
Q4 2015 | $3,619,000 | -10.1% | 778,211 | -4.1% | 0.36% | -38.1% |
Q3 2015 | $4,024,000 | – | 811,227 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aveo Capital Partners, LLC | 93,258 | $47,000 | 0.02% |
Tekla Capital Management LLC | 811,227 | $405,000 | 0.02% |
Virtu Financial LLC | 68,000 | $34,000 | 0.00% |
ROYCE & ASSOCIATES LP | 326,147 | $163,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 776 | $0 | 0.00% |
NORTHERN TRUST CORP | 14,074 | $7,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 11,124 | $6,000 | 0.00% |
DEUTSCHE BANK AG\ | 352,030 | $175,000 | 0.00% |
CREDIT SUISSE AG/ | 20,000 | $10,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 88,994 | $44,000 | 0.00% |